Cardiac magnetic resonance in hypertrophic cardiomyopathy: current state of the art

Hypertrophic cardiomyopathy is a complex disorder with significant heterogeneity in clinical characteristics and natural history. Traditionally, the diagnosis has been based on clinical assessment and echocardiography; however, persistent challenges in its noninvasive evaluation remain. Hence, improved diagnostic techniques could lead to better risk stratification of patients, which would potentially identify patients likely to benefit from effective therapies. Recent studies have demonstrated the increasing utility of cardiac magnetic resonance in the management of this disease. With the increasing utilization of genetics, cardiac magnetic resonance is likely to play an even more important role in discerning the subtle morphologic differences seen in such patients with similar genotypic profiles.

[1]  M. Desai,et al.  Management of hypertrophic cardiomyopathy. , 1993, Heart disease and stroke : a journal for primary care physicians.

[2]  N. Smedira,et al.  Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. , 2009, Journal of the American College of Cardiology.

[3]  M. Desai,et al.  Aortic stiffness is increased in hypertrophic cardiomyopathy with myocardial fibrosis: novel insights in vascular function from magnetic resonance imaging. , 2009, Journal of the American College of Cardiology.

[4]  N. Smedira,et al.  Steep left ventricle to aortic root angle and hypertrophic obstructive cardiomyopathy: study of a novel association using three-dimensional multimodality imaging , 2009, Heart.

[5]  W. Manning,et al.  Response to Letter Regarding Article, “Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy” , 2009 .

[6]  Scott D Flamm,et al.  Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[7]  B. Hamm,et al.  Gender‐specific differences in left ventricular remodelling and fibrosis in hypertrophic cardiomyopathy: Insights from cardiovascular magnetic resonance , 2008, European journal of heart failure.

[8]  Luigi Rega,et al.  Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2008, Journal of the American College of Cardiology.

[9]  W. Manning,et al.  Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. , 2008, Journal of the American College of Cardiology.

[10]  W. Manning,et al.  Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2008, The American journal of cardiology.

[11]  Mario J. Garcia,et al.  Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study , 2008, The International Journal of Cardiovascular Imaging.

[12]  Mario J. Garcia,et al.  Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy , 2007, Heart.

[13]  M. Robson,et al.  Evidence for Microvascular Dysfunction in Hypertrophic Cardiomyopathy: New Insights From Multiparametric Magnetic Resonance Imaging , 2007, Circulation.

[14]  A. Tajik,et al.  Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. , 2007, Journal of the American College of Cardiology.

[15]  Christine E Seidman,et al.  A Contemporary Approach to Hypertrophic Cardiomyopathy , 2006, Circulation.

[16]  M. Laakso,et al.  Cine MR imaging of myocardial contractile impairment in patients with hypertrophic cardiomyopathy attributable to Asp175Asn mutation in the alpha-tropomyosin gene. , 2005, Radiology.

[17]  Michael Jerosch-Herold,et al.  Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy , 2005, Circulation.

[18]  D. Pennell,et al.  Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I , 2005, Heart.

[19]  Raad Mohiaddin,et al.  How we perform cardiovascular magnetic resonance flow assessment using phase-contrast velocity mapping. , 2005, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[20]  M. Götte,et al.  Early Onset and Progression of Left Ventricular Remodeling After Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy , 2005, Circulation.

[21]  R. Falk,et al.  Cardiovascular magnetic resonance in cardiac amyloidosis. , 2005, Circulation.

[22]  P. Dimitrow,et al.  Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. , 2004, Magnetic Resonance Imaging.

[23]  J. Lima,et al.  Cardiovascular magnetic resonance imaging: current and emerging applications. , 2004, Journal of the American College of Cardiology.

[24]  D. Pennell,et al.  Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography , 2004, Heart.

[25]  Richard D. White,et al.  Quantitative assessment of myocardial scar in delayed enhancement magnetic resonance imaging , 2003, Journal of magnetic resonance imaging : JMRI.

[26]  P. Elliott,et al.  Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. , 2003, Journal of the American College of Cardiology.

[27]  Daniel B Ennis,et al.  Assessment of regional systolic and diastolic dysfunction in familial hypertrophic cardiomyopathy using MR tagging , 2003, Magnetic resonance in medicine.

[28]  D. Pennell,et al.  Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. , 2003, Journal of the American College of Cardiology.

[29]  M. Komajda,et al.  Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy , 2003, Circulation.

[30]  F. T. ten Cate,et al.  Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. , 2003, Journal of the American College of Cardiology.

[31]  B. Maron,et al.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.

[32]  Heiko Mahrholdt,et al.  Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[33]  R. Kim,et al.  Reproducibility of Chronic Infarct Size Measurement by Contrast-Enhanced Magnetic Resonance Imaging , 2002, Circulation.

[34]  D. Pennell,et al.  Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. , 2002, The American journal of cardiology.

[35]  B. Maron Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.

[36]  B. Maron,et al.  Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[37]  B. Maron,et al.  Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy , 2001, Circulation.

[38]  H. Mabuchi,et al.  Collagen remodeling and cardiac dysfunction in patients with hypertrophic cardiomyopathy: The significance of type III and VI collagens , 2001, Clinical cardiology.

[39]  P. Elliott,et al.  Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy , 2001, The Lancet.

[40]  P. Elliott,et al.  Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. , 2000, Journal of the American College of Cardiology.

[41]  M. Sherrid,et al.  Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy. , 2000, Journal of the American College of Cardiology.

[42]  B. Maron,et al.  Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[43]  J. Schulz-Menger,et al.  The value of magnetic resonance imaging of the left ventricular outflow tract in patients with hypertrophic obstructive cardiomyopathy after septal artery embolization. , 2000, Circulation.

[44]  H. Watkins Sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[45]  O. Simonetti,et al.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. , 1999, Circulation.

[46]  B. Maron,et al.  Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. , 1999, JAMA.

[47]  T. Imaizumi,et al.  Exercise-induced abnormal blood pressure responses are related to subendocardial ischemia in hypertrophic cardiomyopathy. , 1998, Journal of the American College of Cardiology.

[48]  W. Mckenna,et al.  Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction. , 1998, American heart journal.

[49]  B. Maron,et al.  Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population , 1998, Heart.

[50]  H. Watkins,et al.  Sudden death due to troponin T mutations. , 1997, Journal of the American College of Cardiology.

[51]  M. Burch,et al.  Hypertrophic cardiomyopathy. , 1994, Archives of disease in childhood.

[52]  A. Crawley,et al.  Left Ventricular Wall Thickness and Regional Systolic Function in Patients With Hypertrophic Cardiomyopathy: A Three‐dimensional Tagged Magnetic Resonance Imaging Study , 1994, Circulation.

[53]  L. Axel,et al.  Regional Heterogeneity of Function in Hypertrophic Cardiomyopathy , 1994, Circulation.

[54]  B. Maron,et al.  Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history. , 1993, The American journal of cardiology.

[55]  W. Roberts,et al.  Morphological Determinants of Echocardiographic Patterns of Mitral Valve Systolic AnteriorMotion in Obstructive Hypertrophic Cardiomyopathy , 1993, Circulation.

[56]  W. Roberts,et al.  Diversity of Structural Mitral Valve Alterations in Hypertrophic Cardiomyopathy , 1992, Circulation.

[57]  W. Roberts,et al.  Anomalous Insertion of Papillary Muscle Directly Into Anterior Mitral Leaflet in Hypertrophic Cardiomyopathy: Significance in Producing Left Ventricular Outflow Obstruction , 1991, Circulation.

[58]  H. Schulte,et al.  [Hypertrophic obstructive cardiomyopathy]. , 1990, Deutsche Krankenpflegezeitschrift.

[59]  M. Z. Berisso,et al.  Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. , 1989, The New England journal of medicine.

[60]  W. Stewart,et al.  Long-term follow-up of patients with left ventricular outflow tract obstruction after Carpentier ring mitral valvuloplasty. , 1988, Circulation.

[61]  E. Nabel,et al.  Variability of transient myocardial ischemia in ambulatory patients with coronary artery disease. , 1988, Circulation.

[62]  W. Roberts,et al.  Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. , 1986, Journal of the American College of Cardiology.

[63]  I. Kronzon,et al.  Long-term follow-up after mitral valve reconstruction: incidence of postoperative left ventricular outflow obstruction. , 1986, Circulation.

[64]  R. Bonow,et al.  Obstructive hypertrophic cardiomyopathy associated with minimal left ventricular hypertrophy. , 1984, American Journal of Cardiology.

[65]  J. Griffith,et al.  Mechanism of left ventricular outlfow obstruction in patients with obstructive asymmetric septal hypertrophy (idiopathic hypertrophic subaortic stenosis). , 1975, The American journal of cardiology.

[66]  M. Dunn,et al.  Anterior‐Superior Displacement of Papillary Muscles Producing Obstruction and Mitral Regurgitation in Idiopathic Hypertrophic Subaortic Stenosis: Operative Relief by Posterior‐Superior Realignment of Papillary Muscles Following Ventricular Septal Myectomy , 1974, Circulation.

[67]  L. J. Krovetz,et al.  Distalward Modification of the Arterial Pulse Wave in Children with Congenital Aortic Stenosis , 1974, Circulation.

[68]  C. Lambrew,et al.  Idiopathic Hypertrophic Subaortic Stenosis: I. A Description of the Disease Based Upon an Analysis of 64 Patients , 1964, Circulation.

[69]  N. Smedira,et al.  Abnormally thickened papillary muscle resulting in dynamic left ventricular outflow tract obstruction: an unusual presentation of hypertrophic cardiomyopathy. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[70]  N. Smedira,et al.  Papillary muscle realignment for symptomatic left ventricular outflow tract obstruction. , 2008, The Journal of thoracic and cardiovascular surgery.

[71]  M. Sheppard,et al.  The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[72]  J. Schulz-Menger,et al.  Left ventricular outflow tract planimetry by cardiovascular magnetic resonance differentiates obstructive from non-obstructive hypertrophic cardiomyopathy. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[73]  L. Shaw,et al.  Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. , 2004, European heart journal.

[74]  O. Simonetti,et al.  An improved MR imaging technique for the visualization of myocardial infarction. , 2001, Radiology.

[75]  W. Roberts,et al.  Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. , 2000, Journal of the American College of Cardiology.

[76]  D J Pennell,et al.  Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. , 2000, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[77]  J. Towbin,et al.  Impact of Laboratory Molecular Diagnosis on Contemporary Diagnostic Criteria for Genetically Transmitted Cardiovascular Diseases : Hypertrophic Cardiomyopathy , Long-QT Syndrome , and Marfan Syndrome , 1998 .

[78]  P. D. Collins,et al.  Anomalous papillary muscle as a cause of left ventricular outflow tract obstruction in an adult. , 1997, The Annals of thoracic surgery.

[79]  N. Krasnow An acquired disease component in hypertrophic cardiomyopathy: new clinical clarifications. , 1989, Journal of the American College of Cardiology.